Cyclosol LA 200 mg/ml solution for injection for cattle and pigs. Ireland - English - HPRA (Health Products Regulatory Authority)

cyclosol la 200 mg/ml solution for injection for cattle and pigs.

eurovet animal health b.v. - oxytetracycline dihydrate - solution for injection - 200 milligram(s)/millilitre - oxytetracycline - cattle, pigs - antibacterial

CYCLOSOL 200 LA SOLUTION Canada - English - Health Canada

cyclosol 200 la solution

eurovet animal health b.v. - oxytetracycline (oxytetracycline dihydrate) - solution - 200mg - oxytetracycline (oxytetracycline dihydrate) 200mg - cattle; swine (pigs)

CYCLOSOL LA 200MG/ML SOLUTION FOR INJECTION Ireland - English - HPRA (Health Products Regulatory Authority)

cyclosol la 200mg/ml solution for injection

eurovet animal health b.v. - oxytetracycline (as oxytetracycline dihydrate ph. eur.) - solution for injection - 200 mg/ml - oxytetracycline - bovine, porcine - antibacterial

Cyclosol LA, 200 mg/ml Solution for Injection United Kingdom - English - VMD (Veterinary Medicines Directorate)

cyclosol la, 200 mg/ml solution for injection

eurovet animal health b.v. - oxytetracycline - solution for injection - antimicrobial - cattle, pigs

Cyclosol La 200 mg/mL Solution For Injection (Im/Sc) Philippines - English - FDA (Food And Drug Administration)

cyclosol la 200 mg/ml solution for injection (im/sc)

inphilco, inc.; distributor: inphilco, inc. - oxytetracycline (as dihydrate) (vet.) - solution for injection (im/sc) - 200 mg/ml

Cyclosol 200 Long Acting 200 mg/ml inj. sol. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cyclosol 200 long acting 200 mg/ml inj. sol. i.m. vial

dechra veterinary products sa-nv - oxytetracycline dihydrate 216 mg/ml - eq. oxytetracycline 200 mg/ml - solution for injection - 200 mg/ml - oxytetracycline dihydrate 216 mg/ml - oxytetracycline - cattle; pig

CYCLOSPORINE- cyclosporine capsule United States - English - NLM (National Library of Medicine)

cyclosporine- cyclosporine capsule

eon labs, inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 25 mg - cyclosporine capsules usp (modified) are indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. cyclosporine capsules usp (modified) have been used in combination with azathioprine and corticosteroids. cyclosporine capsules usp (modified) are indicated for the treatment of patients with severe active, rheumatoid arthritis where the disease has not adequately responded to methotrexate. cyclosporine capsules usp (modified) can be used in combination with methotrexate in rheumatoid arthritis patients who do not respond adequately to methotrexate alone. cyclosporine capsules usp (modified) are indicated for the treatment of adult, nonimmunocompromised patients with severe (i.e., extensive and/or disabling), recalcitrant, plaque psoriasis who have failed to respond to at least one systemic therapy (e.g., puva, retinoids, or methotrexate) or in patients for whom other systemic therapies are contraindicated, or cannot be tolerated. while rebound rarely occurs, most patie

CYCLOSPORINE capsule, liquid filled United States - English - NLM (National Library of Medicine)

cyclosporine capsule, liquid filled

physicians total care, inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 100 mg - cyclosporine capsules, usp are indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. it is always to be used with adrenal corticosteroids. the drug may also be used in the treatment of chronic rejection in patients previously treated with other immunosuppressive agents.    cyclosporine capsules are contraindicated in patients with a hypersensitivity to cyclosporine or to any of the ingredients of the formulation.

CYCLOSERINE capsule United States - English - NLM (National Library of Medicine)

cycloserine capsule

parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - cycloserine 250 mg in 250 mg - cycloserine is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, cycloserine should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. cycloserine may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram–positive and gram–negative bacteria, especially enterobacter spp. and escherichia coli. it is generally no more and is usually less effective than other antimicrobial agents in the treatment of urinary tract infections caused by bacteria other than mycobacteria. use of cycloserine in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be

CYCLOSPORINE injection, solution United States - English - NLM (National Library of Medicine)

cyclosporine injection, solution

padagis us llc - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 50 mg in 1 ml - cyclosporine is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. it is always to be used with adrenal corticosteroids. the drug may also be used in the treatment of chronic rejection in patients previously treated with other immunosuppressive agents. because of the risk of anaphylaxis, cyclosporine injection should be reserved for patients who are unable to take the soft gelatin capsules or oral solution. cyclosporine injection is contraindicated in patients with a hypersensitivity to cyclosporine and/or cremophor® el (polyoxyethylated castor oil).